Hsp60 chaperonopathies and chaperonotherapy: targets and agents.
about
Chaperones in hepatitis C virus infectionDisease-Associated Mutations in the HSPD1 Gene Encoding the Large Subunit of the Mitochondrial HSP60/HSP10 Chaperonin ComplexSelective targeting of the stress chaperome as a therapeutic strategyHuman Hsp60 with its mitochondrial import signal occurs in solution as heptamers and tetradecamers remarkably stable over a wide range of concentrations.Heat shock protein 60 overexpression is associated with the progression and prognosis in gastric cancerLabel-free LC-MSe in tissue and serum reveals protein networks underlying differences between benign and malignant serous ovarian tumors.Hsp60 response in experimental and human temporal lobe epilepsyEvidence for a role of autoantibodies to heat shock protein 60, 70, and 90 in patients with dermatitis herpetiformis.Anticancer Gold(III) Porphyrins Target Mitochondrial Chaperone Hsp60.Stress chaperone mortalin regulates human melanogenesis.The Chemical Biology of Molecular Chaperones--Implications for Modulation of ProteostasisNeonatal Death and Heart Failure in Mouse with Transgenic HSP60 Expression.Alcoholic Liver Disease: A Mouse Model Reveals Protection by Lactobacillus fermentumCharacterization and function analysis of Hsp60 and Hsp10 under different acute stresses in black tiger shrimp, Penaeus monodonBoron-Based Drug Design.Exosomal HSP60: a potentially useful biomarker for diagnosis, assessing prognosis, and monitoring response to treatment.Targeting Heat Shock Proteins 60 and 70 of Toxoplasma gondii as a Potential Drug Target: In Silico Approach.Heat shock protein 60 levels in tissue and circulating exosomes in human large bowel cancer before and after ablative surgery.Immunohistochemistry of Human Hsp60 in Health and Disease: From Autoimmunity to Cancer.Chaperonin of Group I: Oligomeric Spectrum and Biochemical and Biological Implications.Effects of Conjugated Linoleic Acid Associated With Endurance Exercise on Muscle Fibres and Peroxisome Proliferator-Activated Receptor γ Coactivator 1 α Isoforms.Anabolic androgenic steroids and carcinogenicity focusing on Leydig cell: a literature review.Toward Developing Chemical Modulators of Hsp60 as Potential Therapeutics.Quantitative analysis of the impact of a human pathogenic mutation on the CCT5 chaperonin subunit using a proxy archaeal ortholog.Physical Exercise Enhanced Heat Shock Protein 60 Expression and Attenuated Inflammation in the Adipose Tissue of Human Diabetic Obese.Single-Ring Intermediates Are Essential for Some Chaperonins.Chaperonology: The Third Eye on Brain Gliomas.Exosomal Chaperones and miRNAs in Gliomagenesis: State-of-Art and Theranostics PerspectivesHeat Shock Proteins in Alzheimer's Disease: Role and TargetingQuaternary structures of GroEL and naïve-Hsp60 chaperonins in solution: a combined SAXS-MD study
P2860
Q26771251-BC527C2D-D4D5-4F85-8C99-23B04BC9EDABQ28069690-EA7593DA-E65B-4B11-A97C-8D04906A32B1Q28248791-CCBA4184-95D7-4B03-82A8-55F87200CE4FQ33618484-5134E3A4-0375-4D15-9E05-6DC6A719ED04Q34160552-055E9EEA-0416-4E00-A6F2-C9F8BDBC72FDQ34267969-368C0E94-FDE6-4F27-AC76-D443513FF08CQ35210709-7DFB390B-A920-4F1D-A778-970D4F78A6A1Q35319481-633FBA01-7810-429A-B5BC-C02E8860D03FQ35867952-6E796761-2114-406F-9BCC-CF5BC94EAF07Q35983240-80B48B03-A1BF-4083-BA8E-CC6E75D86A96Q36059002-C73911DC-BA5A-414C-913D-0A2FFEC46547Q36172956-80E71DCC-F2D7-4288-B28C-B5F01916102EQ36534734-B501F51D-AA8F-49C8-86AF-F7683DF67055Q36674111-43A3D5F0-A6FC-403C-92B7-B6D11FF1AF6BQ38387948-8D5EE698-ABB7-49FC-90AE-4825AF0DA75EQ38674303-0912F9BC-345C-4781-8CEC-4A6057D4CFA3Q40617803-2FD98D1A-66C2-4373-91A8-EA22FEA74266Q40851766-F0146705-C325-4A7C-919E-CAD005B7C058Q49608238-19766567-ECCC-47A6-B713-2EDF1C4E8586Q50104570-B256F8C7-433B-4BA4-9E4C-76E60AE1ED7FQ51597295-41404694-B620-4060-9FA7-72D1C8AF5458Q53688645-53EA7DF0-FF14-4CC3-8659-FC649055837CQ55154018-10921EF4-5062-4820-80E9-09D79C45C682Q55178308-34989EDF-618A-4A50-A717-E2D356E72BB2Q55265913-FD0FA7A0-462D-4292-9624-E69E114D18DBQ55520903-E56F43E3-6D95-458B-9B8F-1789E54E254EQ55714960-1BF3385C-BF8B-44EB-8614-761D3274147AQ58762482-5FBAD99B-204E-4D77-A495-D2811A20B729Q58773462-F0AB8D3B-649B-440A-93F4-BC5A630748D2Q59203947-0ABE4831-712B-40B4-8E6F-9162E9A9716C
P2860
Hsp60 chaperonopathies and chaperonotherapy: targets and agents.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Hsp60 chaperonopathies and chaperonotherapy: targets and agents.
@en
type
label
Hsp60 chaperonopathies and chaperonotherapy: targets and agents.
@en
prefLabel
Hsp60 chaperonopathies and chaperonotherapy: targets and agents.
@en
P2093
P2860
P50
P1476
Hsp60 chaperonopathies and chaperonotherapy: targets and agents.
@en
P2093
Alberto J L Macario
Claudia Campanella
Everly Conway de Macario
P2860
P304
P356
10.1517/14728222.2014.856417
P407
P577
2013-11-29T00:00:00Z